Evidence map›Paper›PMID 30276826›Full record

ReviewAllergy2019

Bronchiolitis needs a revisit: Distinguishing between virus entities and their treatments.

Tuomas Jartti, Hermelijn H Smits, Klaus Bønnelykke, Ozlem Bircan, Varpu Elenius, Jon R Konradsen, Paraskevi Maggina, Heidi Makrinioti, Jakob Stokholm, Gunilla Hedlin and 9 more

Open access · hybridAbstract readReview
In one paragraph

Review in Allergy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed, 3 pooled it
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 3 syntheses or guidelines pooled it, 161 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Trial
  5. Trial
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Association of fever and infections with the subsequent risk of atopic diseases in children with genetic susceptibility for T1D: Results from the TEDDY cohort study.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2025
    Article
  16. Article
  17. Mannose-binding lectin insufficiency is associated with airway Haemophilus colonization and a higher risk of post-RSV bronchiolitis recurrent wheezing.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2025
    Article
  18. Article
  19. Observational
  20. Article

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 11 institutions in 9 countries.

Tuomas JarttiDepartment of Pediatrics, Turku University Hospital and University of Turku, Turku, Finland.ORCID 0000-0003-2748-5362
Hermelijn H SmitsDepartment of Parasitology, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0001-9279-2890
Klaus BønnelykkeCOPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0003-2003-1018
Ozlem BircanDepartment of Pediatric Allergy, Istanbul Medeniyet University Göztepe Training and Research Hospital, Istanbul, Turkey.ORCID 0000-0002-5747-7032
Varpu EleniusDepartment of Pediatrics, Turku University Hospital and University of Turku, Turku, Finland.
Jon R KonradsenAstrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.ORCID 0000-0001-7745-8624
Paraskevi MagginaAllergy Department, 2nd Pediatric Clinic, University of Athens, Athens, Greece.ORCID 0000-0003-0422-3570
Heidi MakriniotiImperial College Healthcare NHS Trust, London, UK.
Jakob StokholmCOPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0003-4989-9769
Gunilla HedlinAstrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
Nikolaos PapadopoulosAllergy Department, 2nd Pediatric Clinic, University of Athens, Athens, Greece.ORCID 0000-0002-4448-3468
Marek RuszczynskiDepartment of Pediatrics, Medical University of Warsaw, Warsaw, Poland.
Klaudia RyczajDepartment of Pediatric Pneumonology and Allergy, Medical University of Warsaw, Warsaw, Poland.ORCID 0000-0002-3037-6944
Bianca SchaubPediatric Allergology, Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, German Center for Lung Research (DZL), LMU Munich, Munich, Germany.
Jürgen SchwarzeCentre for Inflammation Research, Queen's Medical Research Institute and Child Life and Health, University of Edinburgh, Edinburgh, UK.ORCID 0000-0002-6899-748X
Chrysanthi SkevakiInstitute of Laboratory Medicine, Philipps Universität Marburg, Marburg, Germany.ORCID 0000-0001-5194-5635
Katarina Stenberg-HammarAstrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
Wojciech FeleszkoDepartment of Pediatric Pneumonology and Allergy, Medical University of Warsaw, Warsaw, Poland.ORCID 0000-0001-6613-2012
EAACI Task Force on Clinical Practice Recommendations on Preschool Wheeze
Karolinska University Hospital · SEMedical University of Warsaw · PLNational and Kapodistrian University of Athens · GRUniversity of Copenhagen · DKUniversity of Turku · FIGerman Center for Lung Research · DEImperial College Healthcare NHS Trust · GBIstanbul Medeniyet University · TRLeiden University Medical Center · NLPhilipps University of Marburg · DEQueen's Medical Centre · GB

Funding

Deutsche Forschungsgemeinschaft C04German Center for Lung Research 82DZL00502/A2Sigrid Juselius Foundation, Helsinki, FinlandUniversities Giessen and Marburg Lung Center
6 · The paper itself

Abstract

Current data indicate that the "bronchiolitis" diagnosis comprises more than one condition. Clinically, pathophysiologically, and even genetically three main clusters of patients can be identified among children suffering from severe bronchiolitis (or first wheezing episode): (a) respiratory syncytial virus (RSV)-induced bronchiolitis, characterized by young age of the patient, mechanical obstruction of the airways due to mucus and cell debris, and increased risk of recurrent wheezing. For this illness, an effective prophylactic RSV-specific monoclonal antibody is available; (b) rhinovirus-induced wheezing, associated with atopic predisposition of the patient and high risk of subsequent asthma development, which may, however, be reversed with systemic corticosteroids in those with severe illness; and (c) wheeze due to other viruses, characteristically likely to be less frequent and severe. Clinically, it is important to distinguish between these partially overlapping patient groups as they are likely to respond to different treatments. It appears that the first episode of severe bronchiolitis in under 2-year-old children is a critical event and an important opportunity for designing secondary prevention strategies for asthma. As data have shown bronchiolitis cannot simply be diagnosed using a certain cutoff age, but instead, as we suggest, using the viral etiology as the differentiating factor.

Indexed as

Adrenal Cortex HormonesAntibodies, MonoclonalBronchiolitisChildChild, PreschoolHumansRespiratory SoundsRespiratory Syncytial VirusesRhinovirusAdrenal Cortex HormonesAntibodies, Monoclonalbronchiolitisrespiratory syncytial virusrhinovirusviruswheezing

Identifiers

PMID30276826
PMCPMC6587559
OpenAlexW2895086809

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.